logo

For the Inventor, By the Inventor

Guangdong, China

Akeso Biopharma, Inc.

Calculating rank
USPTO Granted Patents = 14



Forward Citations = 3

Loading Chart...
Loading Chart...

8 inventors (with patents filed for the assignee):

goldMedal Baiyong Li (14 out of 23 patents)

silverMedal Yu Xia (14 out of 23 patents)

bronzeMedal Zhongmin Maxwell Wang (14 out of 23 patents)

4.  Peng Zhang (12 out of 25 patents)

5.  Xinghua Pang (4 out of 4 patents)

6.  Ying Huang (2 out of 30 patents)

7.  Faming Zhang (2 out of 6 patents)

8.  Gan Xi (2 out of 3 patents)

9.  Peng Zhang (0 patent)


14 patents:

1. 12774344 - ANTI-CD73 ANTIBODY AND USE THEREOF (2026-10-27),
2. 12703743 - ANTI-CD47 MONOCLONAL ANTIBODY AND USE THEREOF (2026-08-11),
3. 12698327 - ANTI-TIGIT ANTIBODY, AND PHARMACEUTICAL COMPOSITION AND USE THEREOF (2026-08-04),
4. 12679887 - ANTI-INTERLEUKIN-17A ANTIBODY, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF (2026-07-14),
5. 12595300 - ANTI-HUMAN P40 PROTEIN DOMAIN ANTIBODY AND USE THEREOF (2026-04-07),
6. 12447208 - Anti-CTLA4 monoclonal antibody or its antigen binding fragments, pharmaceutical compositions and uses (2025-10-21),
7. 12286473 - Anti-IL-1β antibody and pharmaceutical composition thereof and use of same (2025-04-29),
8. 12195527 - Anti-PD-1/VEGFA bifunctional antibody, pharmaceutical composition thereof (2025-01-14),
9. 11680095 - Monoclonal antibody against nerve growth factor, and encoding gene and use thereof (2023-06-20),
10. 11479608 - Anti-CTLA4 antibodies (2022-10-25),
11. 11291720 - Anti-CTLA4 monoclonal antibody or its antigen binding fragments, pharmaceutical compositions and uses (2022-04-05),
12. 11104734 - Anti-PD-1 monoclonal antibody (2021-08-31),
13. 10858433 - Monoclonal antibody against PD-1 and application thereof (2020-12-08),
14. 10449251 - Anti-CTLA4 monoclonal antibody or its antigen binding fragments, pharmaceutical compositions and uses (2019-10-22),
Company Overview
Akeso Biopharma, Inc. is a biopharmaceutical company based in Guangdong, China, focused on the research, development, and commercialization of innovative therapies. The company specializes in monoclonal antibodies and other biologics, targeting various diseases, including cancer and autoimmune disorders. With a commitment to advancing healthcare solutions, Akeso leverages cutting-edge technology and a robust research pipeline to address unmet medical needs, aiming to improve patient outcomes both domestically and globally.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Nov 3 2026

14 Patents

#37 in Guangdong

#2,056 in China

#42,333 in the World

Guangdong, CN
Guangdong, China

Akeso Biopharma, Inc.

Forward Citations = 3

8 inventors:

goldMedal Baiyong Li (14 out of 23 patents)

silverMedal Yu Xia (14 out of 23 patents)

bronzeMedal Zhongmin Maxwell Wang (14 out of 23 patents)

4.  Peng Zhang (12 out of 25 patents)

5.  Xinghua Pang (4 out of 4 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Akeso Biopharma, Inc.. Retrieved from https://idiyas.com/company/akeso-biopharma

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…